Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Immune Design (Nasdaq: IMDZ) is just one of several growing companies in the Puget Sound region developing immunotherapy treatments for cancer ...
The cancer immunotherapy R&D race between Roche, BMS and AstraZeneca is heating up as Roche aggressively plans to move 11 drugs into ...
Roche Holding Ltd. (RHHBY) Plans To Boost Sales By Working On 11 Different Late-Stage Trials ... -Bidness ETC
Newswise — April 14, 2014, New York, NY - Ludwig Cancer Research previewed today the full scope of discoveries to be presented by more than 40 ...
AstraZeneca to present new data of its early stage oncology pipeline at AACR annual meeting 2015 -pharmabiz.com
NeuVax is a first-in-class, HER2-directed cancer immunotherapy under evaluation to prevent breast cancer recurrence after standard of care treatment ...
Cancer biologists hope to harness that untapped power using an approach known as cancer immunotherapy. Orchestrating a successful immune ...
The three together are shown to be more effective treatments by sensitizing the patient's own immune system to enhance immunotherapy, and ...
However, when the cancer has progressed some symptoms include: ... We've been advancing the idea of immunotherapy for cancer for some time.
The human immune system is poised to spring into action at the first sign of a foreign invader, but it often fails to eliminate tumors that arise from the ...
Stimulating both major branches of the immune system halts tumor growth more effectively - Medical Xpress
MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment -Nature.com
The last ten years have seen a renewed interest in how cancer evades the immune system and how white blood cells can be used therapeutically to ...
"I thought that the human immune system is really our best defense against cancer," says Brunie Felding, an investigator at Scripps. "The wellderly ...
This can affect cancer growth in several ways, but importantly they can attract the attention of the body's immune system to attack the cancer.
Promising developments in tackling resistance to blood cancer drugs - Medical Xpress
The mole was a malignant melanoma, the most deadly form of skin cancer, ... 'However, sometimes the immune system is overwhelmed and cannot ...
Herpes Virus Possible Cure for Melanoma - Gazette Review
The antibody, called BI-1206, is able to stop cancer cells 'hiding' from the immune system and has shown great promise in pre-clinical trials. It is part of ...
(Nanowerk News) Seeking a way to stimulate antitumor responses via the immune system, Steven Fiering, PhD, of Norris Cotton Cancer Center at ...
Protein identified which plays crucial role in the rapid growth of tumours
Discovery raises hopes of test that deliver an early accurate diagnosis
Could lead to more targeted treatment for those with worst cancers
Manipulative Microbiomes
Gut bacteria control tumor growth via the mammalian immune system.
According to SkinCancer.org, more people have had skin cancer over the past three decades than all other cancers combined. The OncoTherapy Network is dedicated to helping you find new treatment options for skin cancer and for its most dangerous form – melanoma.
· Triple Therapy for Melanoma
Recent studies on mice have found that a triple combination of BRAF inhibitors, MEK inhibitors, and immunotherapy could improve responses to treatment.
Recent studies on mice have found that a triple combination of BRAF inhibitors, MEK inhibitors, and immunotherapy could improve responses to treatment.
· Anti-Nodal Antibodies May Help Combat Metastatic Melanoma
A growth factor protein called Nodal may have contributed to a new way to help fight metastatic melanoma.
A growth factor protein called Nodal may have contributed to a new way to help fight metastatic melanoma.
· Intralesional Treatment for Metastatic Melanoma
Interest in emerging intralesional therapies is justified by their strong ablative effects, lack of toxicity, and their stimulation of local and systemic immunological responses in melanoma patients.
Interest in emerging intralesional therapies is justified by their strong ablative effects, lack of toxicity, and their stimulation of local and systemic immunological responses in melanoma patients.
Julie's GP said scoliosis was the cause, but an MRI scan revealed the truth
Julie McKenzie, 53, from Bushy, Herts, had a nagging back pain
Her GP assured her it as down to a mild curvature of the spine
But she'd always been strong and active until the pain began in 2013
She used her private medical cover to see a spinal surgeon, Robert Lee
MRI scan revealed her coccyx contained a tumour
"The factors we found that increase risk of pancreatic cancer now allow us to separate patients as either low or high risk," says the study's senior ...
A step towards screening for familial pancreatic cancer - The Australian Financial Review
Mayo Clinic Creates Profile to Identify Patients Most at Risk of Developing Pancreatic Cancer - EndoNurse
shutterstock_227852689 Research supported by PharmaCyte Biotech, Inc., a biotechnology company developing treatments for cancer patients, ...
Magnetic resonance imaging (MRI) screening identified pancreatic lesions in 40% of individuals at high risk forpancreatic cancer, during a recent ...
Cathi Ahearn, another executive for the global pharma giant, added that their PD-L1 drug would be filed for lung and bladder cancer in the "year to ...
FGFR3 mutation analysis identifies low-grade bladder cancer from urine and tissue-based specimens. Test results help urologists to monitor patients, ...
Residents of Haifa were 29% more likely to develop lung cancer than Israelis in other cities, and 26% more likely to be diagnosed with bladder cancer.
Science Daily Cancer News
Stimulating both major branches of the immune system halts tumor growth more effectively, new research shows. Orchestrating a successful immune attack against tumors has proven difficult so far, but the new study suggests that such therapies could be improved by simultaneously activating both arms of the immune system. Until now, most researchers have focused on one of two strategies: attacking tumors with antibodies, which activate the innate immune system, or stimulating T cells, which form the backbone of the adaptive immune system.
The PARD3 gene has been identified by researchers as a tumor suppressor that is inactivated in lung cancer squamous type. PARD3 gene encodes a protein that regulates cell polarization and cell junctions. When the gene is inactivated, errors occur in this cell orientation and in contact with neighboring cells. "Any change affecting this structure promotes tumor development," said a researcher.
Genetically modified Salmonella can be used to kill cancer cells, scientists report. For years, researchers have known that certain strains of bacteria, including Salmonella enterica, can kill cancer cells. Specifically Salmonella enterica Serovar Typhimurium has been shown to not only colonize solid tumors, but also to exhibit an intrinsic antitumor effect. However, in order to use Salmonella as a weapon against cancer in humans, researchers must find a balance between allowing it to kill the cancer and be safe for the patient. This bacteria, commonly known for causing severe food poisoning, can lead to sepsis and death in humans.
A new biomarker has been discovered that makes it possible to identify women with uterine cancer who have a high risk of recurrence. Endometrial cancer of the uterus is the most common form of gynecologic cancer in Europe and North America. The treatment primarily consists of removing the uterus and in some cases offering chemotherapy if the risk of recurrence is deemed high.
Researchers have demonstrated what could become a more precise method for targeting cancer cells for radiation. The method would use cancer-seeking peptides to ferry nanoparticles of gold to the site. The gold then helps focus radiation on the cancer cells.
A new method has been developed to identify a previously unknown structure in a protein called MDMX. MDMX is a crucial regulatory protein that controls p53 -- one of the most commonly mutated genes in cancer.
A gene critical to controlling the body's ability to create blood cells and immune cells from blood-forming stem cells -- known as hematopoietic stem cells -- has been discovered by researchers. Along with helping scientists better understand the body's basic processes, the discovery opens new lines of inquiry about the gene's potential role in cancers known to involve other members of the same gene family, like leukemia, or those where the gene might be highly expressed or mutated.
A new device may bring rapid, accurate molecular diagnosis of tumors and other diseases to locations lacking the latest medical technology. The devise is a smartphone-based device that uses the kind of technology used to make holograms to collect detailed microscopic images for digital analysis of the molecular composition of cells and tissues.
Compared to other types of breast cancer, triple negative breast cancers are often more aggressive and have fewer treatment options. Researchers have identified a molecular mechanism that triple negative breast cancer cells use to survive and grow, and say that if this result is validated in clinical trials, certain women may be identified at high risk for recurrence early, and could be treated more aggressively.
Tambahkan Komentar